Special Edition: Medications in the Pipeline for Cardiometabolic Disease
About this episode
Neil Skolnik interviews Dr. Juan Frias about the latest cardiometabolic medications and their characteristics.
In this special edition of DOC Updates , Neil Skolnik speaks with Dr. Juan Frias, who catalogues the latest cardiometabolic medications, emphasizing the distinguishing characteristics of each. This special episode is sponsored with support from Lilly . Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Juan Pablo Frias , MD, Medical Director and Principal Investigator, Los Angeles Institute for Metabolic Research, Adjunct Professor of Medicine at Charles Drew University of Medicine and Science
Sponsors
Lilly
More episodes of Diabetes Core Update
- Special Edition: What's Next—Once-Weekly Insulins—Mechanisms and Practical Considerations
- Special Edition: What's Next—CKD in Type 1 Diabetes—An Urgent Need for Therapies
- Efficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!
- Special Edition: The Diabetes, Obesity, and CardioMetabolic CARE Symposium—The Cost of Obesity and Its Treatment
- Anna Kahkoska & Joshua Niznik on Patient Portal Messages and Older Adults with T2D, Esben Thyssen Vestergaard on Clinic for Athletes with T1D, and more!
- Food coloring additives & T2D, automated insulin delivery systems in T2D, and more!
Explore listener stats, chart rankings, contacts and more on the Diabetes Core Update podcast page.